Stockreport

Fosun Pharma's application for licensed COVID-19 vaccine product OK'd in China [Seeking Alpha]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF The National Medical Products Administration hasaccepted(BNTX+8.9%The Vaccine candidate is a prophylactic biological product, aiming at the precaution of COVID-19 for pe [Read more]